MRP1 contributes to drug resistance by actively transporting chemotherapeutic agents out of cancer cells. This reduces the intracellular concentration of the drugs, rendering them less effective. The protein uses energy derived from ATP hydrolysis to pump drugs across the cell membrane, thereby protecting the cancer cells from cytotoxic effects.
